The month of September has been a rollercoaster for a product that has in many ways become the face of the consumer genetic testing market, Exact Sciences’ Cologuard. The Growth of Cologuard … [Read more...]
FDA WATCH
Emerging Tests: FDA Breaks New Ground by Clearing EIA Technology-Based Lyme Assays
September 24, 2019
Laboratory diagnosis of Lyme disease is based on detecting the presence of antibodies against Borrelia burgdorferi, the bacteria that causes the disease, in a patient's blood. Traditional testing uses … [Read more...]
INSIDE THE INDUSTRY
Government Report Casts Doubt on Cost-Effectiveness of Leading Genetic Colorectal Cancer Screening Test
September 24, 2019
Few of the newfangled consumer genetic testing products have had greater commercial success and visibility than Exact Science's Cologuard colorectal cancer screening test. But a troubling new … [Read more...]
EMERGING TESTS
Study Finds Liquid Biopsies More Effective than Traditional Biopsies in Detecting Cancer Drug Resistance
September 24, 2019
Liquid biopsies based on blood samples do a better job than traditional biopsies in analyzing both the genetic diversity of the patient's cancer and how tumors evolve drug resistance at the molecular … [Read more...]
INNOVATION
Point of Care: Handheld Device Shows Promise in Detecting Concussion from Blood Samples
September 24, 2019
A handheld portable device could be more effective than a CT scan in detecting mild traumatic brain injuries (TBI), according to a new study published in The Lancet Neurology. Because it is capable of … [Read more...]
EMERGING TESTS
Inside the Industry: Government Report Casts Doubt on Cost-Effectiveness of Leading Genetic Colorectal Cancer Screening Test
September 23, 2019
Few of the newfangled consumer genetic testing products have had greater commercial success and visibility than Exact Science's Cologuard colorectal cancer screening test. But a troubling new … [Read more...]
INDUSTRY TRENDS
Adoption Quickening for Genomic Cancer Testing in Community Settings
September 16, 2019
Clinicians are increasingly using genomic cancer testing in community health care settings, although there are lingering questions about the utility of results. These are the findings of several … [Read more...]
EMERGING TESTS
Top of the News: Early Results Show Blood Test’s Effectiveness in Early Alzheimer’s Detection
August 26, 2019
Developing a cost-effective blood test capable of accurately detecting early Alzheimer's disease that can be furnished at a doctor's office has been a goal for decades. And now comes word that … [Read more...]
EMERGING TESTS
Nonculture Molecular Tests Speed Diagnosis of Bloodstream Infections
August 19, 2019
The T2Bacteria Panel (T2Biosystems; Lexington, Mass.) can rapidly and accurately diagnoses bloodstream infections (BSIs) caused by five common bacteria, according to a study published May 14 in the … [Read more...]
